Strategies in diagnosis and management for advanced or metastatic gastrointestinal stromal tumor.
- Author:
Ying-jiang YE
1
;
Zhi-dong GAO
;
Shan WANG
Author Information
1. Department of Gastrointestinal Surgery, Peking University People's Hospital, Beijing 100044, China.
- Publication Type:Journal Article
- MeSH:
Gastrointestinal Stromal Tumors;
diagnosis;
drug therapy;
pathology;
surgery;
Humans;
Neoplasm Metastasis
- From:
Chinese Journal of Gastrointestinal Surgery
2012;15(3):213-216
- CountryChina
- Language:Chinese
-
Abstract:
With deeper understanding of gastrointestinal stromal tumor(GIST), more and more patients are diagnosed as GIST. Although the prognosis of early GIST is satisfactory after complete surgical resection, there are still many problems in the treatment of advanced GIST. Variety of treatment options has been used in the treatment of GIST, such as surgery, targeted drug therapy, and surgery plus imatinib therapy. However, post-operative recurrence, imatinib-resistance, multi-targeted drug resistance are still challenges. Many clinical evidences show that a reasonable management strategy can improve the prognosis of patients with advanced GIST. All the doctors should have a clear mind to carry out appropriate interventions. Advanced GIST should not be simply considered to be either medical or surgical disease, but rather must be systematically managed by multidisciplinary team approach combining surgical oncology, medical oncology, pathology, and interventional medicine. This review will advocate suitable treatment strategies based on the most recent progresses in systemic treatment for advanced GIST and our clinical experience to achieve early detection, early prevention, proper management, and therefore improve the survival of these patients.
